Glioma of Brain Clinical Trials

5 recruiting

Glioma of Brain Trials at a Glance

14 actively recruiting trials for glioma of brain are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Phase 1 with 4 trials, with the heaviest enrollment activity in Leuven, San Francisco, and Boston. Lead sponsors running glioma of brain studies include Universitaire Ziekenhuizen KU Leuven, University of California, San Francisco, and Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta.

Browse glioma of brain trials by phase

Treatments under study

About Glioma of Brain Clinical Trials

Looking for clinical trials for Glioma of Brain? There are currently 5 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Glioma of Brain trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Glioma of Brain clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 114 of 14 trials

Recruiting
Phase 2

Dabrafenib and Trametinib for BRAF V600 Mutant Low-Grade Gliomas

BRAF V600 MutationLow-grade GliomaLow Grade Glioma of Brain+1 more
University of California, San Francisco96 enrolled5 locationsNCT07110246
Recruiting
Early Phase 1

Evaluation of 18F-Fluciclovine Positron Emission Tomography - Magnetic Resonance Imaging (PET-MRI) in LGG

GliomaGlioma, MalignantLow-grade Glioma+2 more
Children's Hospital of Philadelphia30 enrolled1 locationNCT05555550
Recruiting

Patient Voice in the Treatment of Low-grade Gliomas: Use of Patient-reported Outcomes, Vorasidenib and Radiotherapy Compared

GliomaGlioma of BrainLow Grade Glioma of Brain+2 more
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta90 enrolled1 locationNCT07547163
Recruiting
Phase 2

A Study Utilizing Escitalopram in Glioma Patients

GliomaGlioma of Brain
University of Nebraska20 enrolled1 locationNCT03728673
Recruiting
Not Applicable

Efficacy of Laser Interstitial Thermal Therapy in Young Persons With Low-grade Glioma

Pediatric CancerLow-grade GliomaLow Grade Glioma of Brain+1 more
University of California, San Francisco40 enrolled1 locationNCT07506239
Recruiting
Phase 1

GD2 CAR T Cells in Diffuse Intrinsic Pontine Gliomas (DIPG) & Spinal Diffuse Midline Glioma(DMG)

Glioma of Spinal CordGlioma of Brainstem
Stanford University97 enrolled1 locationNCT04196413
Recruiting
Phase 1

Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma.

Brain TumorBrain CancerGlioblastoma+6 more
Henry Ford Health System18 enrolled1 locationNCT05686798
Recruiting
Not Applicable

Measure of the Potential Evoked by Electric Stimulation

Low Grade Glioma of Brain
University Hospital, Montpellier12 enrolled1 locationNCT02509442
Recruiting
Early Phase 1

Implantable Microdevice In Primary Brain Tumors

GlioblastomaAstrocytomaGrade II Glioma+5 more
Oliver Jonas12 enrolled1 locationNCT04135807
Recruiting
Phase 1

ViCToRy: Vorasidenib in Combination With Tumor Specific Peptide Vaccine for Recurrent IDH1 Mutant Lower Grade Gliomas

Low Grade Glioma of Brain
Katy Peters, MD, PhD48 enrolled1 locationNCT05609994
Recruiting
Phase 1Phase 2

Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM

CancerBrain TumorBrain Cancer+6 more
Northwell Health67 enrolled1 locationNCT03213002
Recruiting

Longitudinal Analysis of the Health-related Quality of Life in Glioma Patients

Glioma of Brain
Universitaire Ziekenhuizen KU Leuven750 enrolled1 locationNCT03849430
Recruiting
Not Applicable

HyperSpectral Imaging in Low Grade Glioma

Low Grade Glioma of Brain
Universitaire Ziekenhuizen KU Leuven10 enrolled1 locationNCT04859725
Recruiting
Phase 2Phase 3

Neuropsychological and Oncological Outcomes in Grade 2 or 3 Glioma Patients Undergoing Postoperative Modern Radiotherapy

Glioma of Brain
Chang Gung Memorial Hospital80 enrolled1 locationNCT03534050